Tazarotene 0.045% Lotion for Truncal Acne: Efficacy, Safety, and Spreadability

Main Article Content

Leon Kircik
Zoe Draelos
Eric Guenin

Keywords

Acne, Tazarotene Lotion

Abstract

N/A

References

1. Del Rosso JQ. Cutis. 2006;77:285–289.

2. Dréno B, et al. JEADV. 2015;29(6):1096–1106.

3. Poli F, et al. JEADV. 2020;34(10):2241–2246.

4. Short RW, et al. Pediatr Dermatol. 25(1):126–128.

5. Kim BR, et al. Dermatol. 231:87–93.

6. Tanghetti EA, et al. J Dermatol Treat. 2019;Sept 26:1–8.

7. Kircik LH, et al. J Dermatol Treat. 2121;Aug 30:1–9.

8. Draelos ZD, et al. J Drugs Dermatol. 2021;21(3):250–257.

Most read articles by the same author(s)

1 2 3 4 5 6 7 > >>